Table 1.
Controls N = 8373 |
Cases N = 3501 |
||||
---|---|---|---|---|---|
Variable | n | (%) | n | (%) | P value* |
Sex | 0.99 | ||||
Female | 2679 | (32.0) | 1120 | (32.0) | |
Male | 5694 | (68.0) | 2381 | (68.0) | |
Age group (years) | 0.07 | ||||
20-39 | 2979 | (35.6) | 1203 | (34.4) | |
40-64 | 3820 | (45.6) | 1578 | (45.1) | |
65-84 | 1574 | (18.8) | 720 | (20.6) | |
Age (years), mean (standard deviation)† | 48.6 | (15.8) | 49.2 | (16.0) | 0.03 |
Fluvastatin | 0.39 | ||||
No use | 8328 | (99.46) | 3475 | (99.25) | |
Current use | 41 | (0.49) | 23 | (0.66) | |
Late use | 4 | (0.05) | 3 | (0.09) | |
Comorbidities before index date | |||||
Alcohol-related diseases | 1148 | (13.7) | 545 | (15.6) | 0.008 |
Biliary stone | 715 | (8.54) | 406 | (116) | < 0.001 |
Cardiovascular diseases | 1417 | (16.9) | 666 | (19.0) | 0.006 |
Chronic kidney disease | 115 | (1.37) | 100 | (2.86) | < 0.001 |
Chronic obstructive pulmonary disease | 1123 | (13.4) | 519 | (14.8) | 0.04 |
Diabetes mellitus | 623 | (7.44) | 365 | (10.4) | < 0.001 |
Hepatitis B | 185 | (2.21) | 146 | (4.17) | < 0.001 |
Hepatitis C | 79 | (0.94) | 93 | (2.66) | < 0.001 |
Hyperparathyroidism& | 1 | (0.01) | 9 | (0.26) | <0.001 |
Hypertriglyceridemia | 658 | (7.86) | 336 | (9.60) | 0.002 |
Data are presented as the number of subjects in each group with percentages given in parentheses, or mean with standard deviation given in parentheses.
Chi-square test,
Fisher exact test, and
t test comparing subjects with and without acute pancreatitis.